Structure-based design of aliskiren, a novel orally effective renin inhibitor
- 5 August 2003
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 308 (4), 698-705
- https://doi.org/10.1016/s0006-291x(03)01451-7
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Angiotensin II receptor antagonists role in arterial hypertensionJournal of Human Hypertension, 2002
- Angiotensin II Suppression in Humans by the Orally Active Renin Inhibitor Aliskiren (SPP100)Hypertension, 2002
- Pathways for Angiotensin II Generation in Intact Human TissueHypertension, 1998
- The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressureArchives of Internal Medicine, 1997
- The cardiac renin—angiotensin—aldosterone system and hypertensive cardiac hypertrophyThe American Journal of Cardiology, 1995
- Clinical Pharmacokinetics and Efficacy of Renin InhibitorsClinical Pharmacokinetics, 1995
- Immediate blood pressure effects of the renin inhibitor enalkiren and the angiotensin-converting enzyme inhibitor enalaprilatAmerican Heart Journal, 1991
- A fast algorithm for rendering space-filling molecule picturesJournal of Molecular Graphics, 1988
- EnalaprilDrugs, 1986
- Effects of a specific and long-acting renin inhibitor in the marmoset.Hypertension, 1985